Background/Aims: αB -crystallin (αBC) belongs to the family of small heat shock proteins that are necessary for maintaining oxygen homeostasis. This study was designed to explore the possible effects of αBC on N-methyl-N-nitrosourea (MNU) induced retinal degeneration and the underlying mechanisms. Methods: The αBC was injected into the vitreous bodies of MNU administered mice. The retinal morphology and visual function of experimental animals were analyzed by electroretinography (ERG), Spectral domain optical coherence tomography (SD-OCT), fundus photographs, optokinetic testing and immunohistochemistry assay. Results: Optokinetic behavioural tests and ERG examination suggested that the visual impairments of the MNU administered mice were ameliorated effectively by αBC treatment. OCT analysis showed that the major retinal architecture of the MNU administered mice was efficiently rescued by αBC treatment. Fundus examination suggested that the lesion size of the MNU administered mice was decreased by αBC treatment. MNU induced photoreceptor loss was also mitigated by αBC treatment as shown by hematoxylin and eosin staining. In particular, the immunostaining study suggested that M-cone photoreceptors, rather than the S-cone photoreceptors, were preferentially rescued, indicating that the photoreceptor populations have different sensitivities to αBC. The mechanism study suggested that the anti-apoptotic, anti-oxidative and neurotrophic function of αBC collectively contributed to these therapeutic
Introduction
Retinitis pigmentosa (RP) comprises a heterogeneous group of inherited retinal dystrophies that are characterized by progressive photoreceptor apoptosis. Millions of patients are affected by this ophthalmological disease and eventually become blind [1, 2] . At present, therapeutic approaches for RP remain unsatisfactory owing to the complex etiologies. Therefore, novel strategies are necessary to prevent retinal degeneration as well as visual impairment. Accumulating evidence suggests that divergent mutations cause different RP phenotypes, and these mutations eventually lead to photoreceptor apoptosis [3, 4] . This common cell death mechanism would provide a therapeutic target that is independent of the initial genetic defects. In particular, the oxidative stress plays a pivotal role in initiating photoreceptor apoptosis in RP. This notion is further supported by the fact that multiple antioxidants suppress the photoreceptor degeneration in RP models [5, 6] . N-Methyl-N-nitrosourea (MNU), a direct-acting alkylation toxicant, causes DNA lesions and paralyses the excision repair machinery within the cell nucleus, thereby inducing photoreceptor apoptosis in the mammalian retina [7] . After a single systemic administration, active signs of retinal degeneration, such as reduced outer nuclear layer(ONL) width, degraded electroretinogram (ERG) response, and hyper-expression of apoptotic labeling, occur in mice within 1 week after MNU administered. These characteristics faithfully mimic the pathological events taking place in RP. Therefore, the MNU administered animal has been recognized as a chemically induced RP model with rapid progressive dynamics [8] [9] [10] . Given its high reproducibility and convenience, the MNU induced RP animal model is widely utilized in pathological and therapeutic investigations.
Crystallin is a group of highly abundant proteins that are spatially organized in the ocular lens [11] . The αB -crystallin (αBC) is also expressed in the central neural system and retina as well as the lens. αBC belongs to the family of small heat-shock proteins and acts as a molecular chaperone during multiple cellular processes, including development, neurodegeneration, apoptosis and regenerative tissue repair [12, 13] . The αBC induced beneficial effects in several human diseases have received considerable attention. However, its therapeutic potential in retinal degeneration is beginning to emerge. Recent studies have shown that the αBC is involved in retinal pathologies, as αBC expression is significantly up-regulated in the damaged retina [14] . Furthermore, αBC is deposited in the drusen of age-related macular degeneration (AMD). This alteration is considered to be an adaptive or compensatory response during AMD progression [15, 16] . In therapeutic trials, over expression of αBC in retinal pigment epithelium (RPE) cells could enhance cellular resistance against apoptosis. Conversely, deprivation of αBC would render the RPE cells more susceptible to oxidative and endoplasmic reticulum(ER) stress [17] .The cytoprotective ability of αBC is also demonstrated in photoreceptor cultures(e.g., 661W cells) [18] . Moreover, intravitreal injection of αBC results in axon regeneration in rats after acute optic never injury [19] . A recent proteomic analysis of the vitreous-retinal complex found that αBC contributed significantly to vitreoretinal pathologies [20] .However, much of the aforementioned data are derived from cell culture studies, which cannot be readily translated to RP models, because the mechanisms may differ between in vitro and in vivo experimental conditions.
In this study, we assessed the αBC induced effects on the photoreceptor degeneration of MNU administered mice. The therapeutic agents were injected into vitreous body to determine whether this delivery pathway could alleviate the pathology in the posterior segment of the eye ball. Further mechanism studies might determine the possibility of developing a novel therapy for RP. 
Materials and Methods
Study design and animal models C57BL/6 mice (male, 8 weeks old) were purchased from Laboratory Animal Center of General Hospital of PLA (Beijing, China), and were housed in an air-conditioned laboratory (room temperature: 18℃ to 23℃, humidity: 40% to 65%) on a 12-h light/dark cycle. The care and maintenance of the animals were performed in compliance with the Association for Research in Vision and Ophthalmology's Statement for the use of animals. The design of the treatment protocol was based on the basic pathological feature of animal model and previous pharmacological studies. Typically, the retinal degenerative process in MNU administered mice occurred within 7 days with a dose of 60 mg/kg [21, 22] . This administered dose was considered as the optimum dose for model construction and has been used in multiple therapeutic trials [22, 23] . MNU solution (5 mg/ml) was prepared by dissolving reagent in physiological saline containing 0.05% acetic acid. In order to establish the retinal degeneration model, the mice received a single intraperitoneal injection of MNU (60mg/kg; Sigma;St.Louis,MO). The animals were randomly assigned to three groups: 1) normal control group: no pharmacological administration; 2)MNU group: intravitreal injection of 2 μl phosphatebuffered saline(PBS) 2 h post MNU administration; 3) MNU+αBC group: intravitreal injection of 1 mg αBC 2 h post MNU administration. The intravitreal delivery of reagent was performed as follows: 1 mg purified αBC (U.S.Biological, Swampscott, MA, USA) was dissolved in 2 μl PBS. Lidocaine(0.1%) was applied topically to the eye surface to anaesthetize the cornea. The pupils were dilated with atropine(1%) and phenylephrine hydrochloride(2.5% ) eye drops (Xing Qi, Shenyang, China). The needle of a micro syringe was inserted from the limbus at a 45°angle into the vitreous cavity, and the reagent was slowly injected in. Half a minute after injection, the syringe needle was removed, and neomycin eye drops (Xing Qi, Shenyang, China) were applied to the injected eyes to prevent infection. Mice with postoperative complications including lens opacity, intraocular hemorrhage, and retinal injury were excluded from this study. The choice of αBC dose was based on a previous study [24] . After intraperitoneal injection of MNU, experimental animals required a period of time to recover from trauma. To minimize their suffering, these mice were maintained in shielded cages for 2 hours to determine whether they had any clinical signs or systemic symptoms. If no adverse effect was evident in the MNU administrated animal, the intravitreal injection procedure was then conducted.
SD-OCT examination
One week after MNU administration, the animals were subjected to spectral domain optical coherence tomography (SD-OCT) examination. The pupils of mice were dilated with atropine(1%) and phenylephrine hydrochloride(2.5%) eye drops (Xing Qi, Shenyang, China). Mice were anesthetized with by an intraperitoneal injection of 1 % sodium pentobarbital (2 ml/kg, Lot No.p3761; Sigma-Aldrich Corp.) and sumianxin (0.05 ml, Jilin Shengda Animal Pharmaceutical Co., Ltd., Jilin, China). Subsequently, mice were transferred to the recording plane of the SD-OCT system (Bioptigen ,Durham, NC). A corresponding box was centered on the optic nerve head with eight measurement points separated by 3 mm from each other. The SD-OCT crosssectional images were analyzed with the InVivo VueTM DIVER 2.4 software (Bioptigen, Inc, NC, USA). Neural retinal thickness for the examined eyes was compared at each point by measuring the distance from the vitreous face of the retinal ganglion cell (RGCs) layer to the apical face of the RPE layer.
Fundus photographs
After OCT examination, mice were transferred on a warming plane while it was still anesthetized. The pupils were dilated repeatedly with atropine(1%) and phenylephrine hydrochloride(2.5%) eye drops (Xing Qi, Shenyang, China) to avoid retraction. Retinal structure was visualized and the retinal image was captured with a small animal fundus camera machine (Genesis, Tokyo, Japan). Signs of retinal degeneration, including alterations of the RPE and retinal arteries, and presence or absence of pigmented dots were noted during the examination. 10 mice in each animal group were subjected to the fundus examination. Devastation scale and lesion size were assessed subjectively by an examiner on the basis of photographs from all the mice in each group. 
ERG recording
Mice were dark adapted overnight before ERG examination. Subsequently, mice were anesthetized and their pupils were dilated following the aforementioned protocol. We transferred the mice to the recording platform under dim red light. The cornea of the mouse was anesthetized with a drop of proxymetacaine(0.5%). The RETIport system (Roland Consult, Germany) with custom-made chloride silver electrodes were applied in the recording process. A loop electrode was placed over the cornea to serve as the active electrode. Needle reference and ground electrodes were inserted into the cheek and tail respectively. A brief white flash (3.0 cd·s/m 2 ) was delivered from a Ganzfeld integrating sphere to stimulate the response. A band-pass (1 Hz-300 Hz) was used to amplify the recorded signals. Totally 60 photopic responses and 10 scotopic responses were collected and averaged for a-and b-waves analysis.
Optokinetic testing
Light adapted visual acuities and contrast sensitivities were measured using a two-alternative forced choice paradigm as described previously [25] . Briefly, stepwise functions for correct responses in both the clockwise and counter-clockwise direction were used to determine the response threshold. The initial stimulus in visual acuity measurements was set as 0.200 cyc/deg sinusoidal pattern with a fixed 100% contrast. The initial pattern in contrast sensitivity measurements was set as 100% contrast, with a fixed spatial frequency of 0.128 cyc/deg. All patterns were presented at a speed of 12 degrees/s with the mean luminance of 70cd/m 2 . Visual acuities and contrast sensitivities of each mouse were measured for four times over a period of 24 h.
Histology assessment and Immunohistochemistry
Mice were sacrificed and their eyecups were enucleated. Eyecups were immersed in a fixative solution containing 4% paraformaldehyde (Dulbecco's PBS; Mediatech, Inc., Herndon, VA, USA) for 24 hours. Subsequently, the specimens were rinsed with PBS, dehydrated in a graded ethanol series, and embedded in paraffin wax. Five sections (thickness of 5μm) were cut vertically through the optic nerve head of each eye. The sections were stained with hematoxylin and eosin (HE) and evaluated by light microscopy. Using the Image-Pro Plus software (Media Cybernetics, Silver Spring, MD), the adjacent thickness of the ONL was measured along the vertically superior-inferior axis at 250 μm intervals. The mean ONL thickness of each mouse was averaged from five sections. Then sections were rinsed with 0.01M PBS, permeabilized with 0.3% Triton X-100, and blocked with 3% bovine serum albumin(BSA) for 1 h at room temperature. The peanut agglutinin(PNA) conjugated to Alexa Fluor 488 (1: 200, L21409, Invitrogen, USA), S-cone opsin, and M-cone opsin antibodies (1 : 400,Millipore, MA, USA) diluted in 0.1% Triton X-100 and 1% BSA in PBS. Then, sections were extensively washed with PBS, and incubated with Cy3-conjugated anti-rabbit IgG (1: 400, 711-165-152, Jackson ImmunoResearch Laboratories, PA, USA) and DAPI. Retinal sections were then rapidly rinsed five times with 0.01M PBS, and coverslipped with anti-fade Vectashield mounting medium (Vector Laboratories, Burlingame, CA, USA) for photographing.
TUNEL assay
Three days after MNU administration, the TUNEL (terminal deoxyuridine triphosphate nick-end labeling) assay was performed on paraffin sections to analyze the apoptotic status of the retinas. The in situ cell death detection POD Kit (Roche Diagnostics GmbH, Mannheim Germany) was used according to the manufacturer's protocol. The TUNEL sections were counterstained with DAPI, mounted on slides, and then visualized with confocal microscopy (LSM510, Zeiss, Oberkochen, Germany). The apoptotic index (AI) of ONL was calculated ([number of TUNEL-positive nuclei]/[total number of photoreceptor cell nuclei]×100).
Quantification of SOD activity and MDA content
Three days after MNU administration, the animals were sacrificed and their eyecups were enucleated. Retinal tissue was added into the PBS containing 0.5% Triton X-100(pH 7.4) and homogenized in ice cold by Grinders. Retinal tissue was centrifuged at 500×g for 5 minutes at 4°C. The suspension was assayed for protein contents to normalize enzyme activity. Superoxide dismutase (SOD) activity was examined with the SOD Assay Kit-WST (Jiancheng Biotech Ltd., Nanjing, China). A spectrophotometer with ultra-micro cuvettes was used to measure the absorbance values. The content of malondialdehyde (MDA) was assessed using a total bile acids colorimetric assay under the guidance of the manufacturer's instructions (Jiancheng Biotech Ltd., Nanjing, China).
Quantification of αBC levels in the retinas
Thirty hours after MNU administration, the experimental animals were sacrificed. Their eyes were enucleated and dissected immediately. The neural retina was gently removed from the pigment epithelium layer of the eye-cup. Subsequently, western plot assay was performed to quantify the αBC protein levels in neural retinas of mice.
Western blot analysis
Retinas were cut into pieces and homogenized in buffer containing 0.23 mol/l sucrose, 2 mmol/l EDTA, 5 mmol/l Tris-HCl (pH 7.5), and 0.1 mmol/l phenylmethylsulfonyl fluoride. After centrifugation, aliquot containing equal amounts of protein (20μg) were electrophoresed, transferred, and probed with polyclonal antiserum against STAT3 (Ser727, 1 : 5000, Cell Signaling Technology, MA, USA), or JAK2 (1:1000, Santa Cruz Biotechnology, TX, USA)，or a rabbit anti-αBC (1:1000, Chemicon, CA, USA), anti-CNTF (1:1000, Santa Cruz Biotechnology, TX, USA), anti-BNDF (1:1000, Cell Signaling Technology, MA, USA), anti-pStat3 (1:1000, Cell Signaling Technology, MA, USA), anti-bax (1:1000, Santa Cruz Biotechnology, TX, CA), antibcl 2 (1:1000, Cell Signaling, MA, USA), anti-caspase3 antibody(1:1000, Cell Signaling Technology, MA, USA) or a monoclonal antibody against mouse β-actin (1:3000, Sigma-Aldrich, CA, USA). The membrane was washed thoroughly and then incubated with anti-rabbit or anti-mouse IgG horseradish peroxidase secondary antibodies (1:3000, Santa Cruz Biotechnology, CA). Bands were visualized using an enhanced chemiluminescence detection system (Super Signal West Pico Chemiluminescent Substrate Kit; Pierce, Rockford, IL, USA).
Isolation of mitochondria and analysis of MnSOD
Retinal tissue was washed and homogenized using buffer A [0.3 phenylmethylsulfonyl fluoride, 1 orthovanadate, 1 NaF, 1 EDTA, 10 Tris-HCl, 250 sucrose (in mmol/l)], followed by serial centrifugations (700×g, and 10000×g for 30 min respectively ). The resulted supernatant was collected and defined as the cytosolic fraction, while the mitochondrial pellet was washed, collected and lysed in mitochondria specific buffer B [0.3 PMSF, 1 NaF,1 orthovanadate, 10 EDTA, 20 Tris-HCl, 150 NaCl (in mmol/l), 1% NP-40], followed by 10 min of centrifugation (21000 g). Then the supernatant was carefully collected and subjected to mitochondrial superoxide dismutase (MnSOD) analysis. MnSOD activity was measured using commercially available kits (Beyotime biotechnology, Shanghai, China)under the guidance of the manufacturer's instructions. MnSOD activity was expressed as relative percent of control.
Quantitative real time-polymerase chain reaction (qRT-PCR)
Total RNA was extracted from pooled retinal patches with a commercial reagent (Trizol, Gibco Inc., Grand Island, NY, USA), followed by cDNA synthesis using the μMACS™ DNA Synthesis kit (Miltenyi Biotech GmbH, Bergisch-Gladbach, Germany). GAPDH was used as an internal standard of mRNA expression. Reactions were performed in a real-time CFX96 Touch PCR detection system (Bio-Rad Laboratories, Reinach, Switzerland). The amplification program consisted of polymerase activation at 95°C for 5min and 50 cycles of denaturation at 95°C for 1 min, annealing and extension at 59°C for 30 seconds. The primers used in qRT-PCR were: Bax:5'-AGCTCTGAACAGATCATGAAGACA3'(forward)and5'-CTCCATGTTGTTGT CCAGTTC ATC3' (reverse);Bcl-2:5'GGACAACATCGCTCTGTGGATGA3'(forward)and5'CAGAGACAGCCAGGAGAAATCAA 3'(reverse);Caspase-3:5'TGTCGATGCAGCTAACC3'(forward)and5'GGCCTCCACTGGTATCTTCTG3'(reverse); CNTF: 5'-CCT CTG TAG CCG TTC TAT CTG-3′(forward)and 5'-GGT TCT CTT GGA GTC GCT CT-3′; BNDF: 5′-AAG GTG GAT GAG AGT TGA AG-3'(forward) and 5'-GAT GCT GGA AGG TAA TGT GT-3'(reverse). Relative expression levels were normalized and quantified to obtain the ΔΔCT values (DATA assist Software v2.2, Applied Biosystems). 
Statistical analysis
The statistical difference between the animal groups was processed using the ANOVA analysis followed by Bonferroni's post-hoc test. P<0.05 was considered as statically significant. The values are presented as mean ±standard deviation.
Results

αBC levels in the neural retinas of experimental animals
Western plot was performed to quantify αBC protein levels in the neural retina of animals in the three groups (Fig. 1.A) . The retinal αBC level was significantly higher in the MNU+αBC group than in the normal control group (P <0.01; n=10; Fig. 1.B) and the MNU group (P <0.01; n=10). Moreover, the retinal αBC protein level was not significantly different in the MNU group and the normal control group (P>0.05; n=10).These findings suggest that the exogenously delivered αBC could reach the sensory retina. Intravitreal injection could act as an effective approach for αBC delivery.
αBC induced protective effects on visual function
The optokinetic behavioral test suggested that the MNU group responded extremely poorly to the stimulus: both visual acuity and contrast sensitivity of the MNU group were significantly lower compared with the normal control (P < 0.01; n = 10). Meanwhile, the MNU+αBC mice responded better than the MNU group: visual acuity and contrast sensitivity of the MNU+αBC group were both significantly higher compared with the MNU group (P < Fig. 1 . A. Western plot was performed to quantify the αBC protein levels in the neural retina of mice. B. Retinal αBC level in the MNU+αBC group was significantly increased than those in the normal control group and the MNU group.C. Optokinetic behavioral analysis suggested that mice in the MNU group responded poorly to stimulus. Visual acuity in the MNU group was significantly lower compared with the normal control group, whereas visual acuity in the MNU+αBC group was significantly higher compared with the MNU group. D. Contrast sensitivity in the MNU+αBC group was significantly higher compared with the MNU group, suggesting that optokinetic function of MNU administered mouse was rescued by αBC treatment (All the values were presented as mean ±SD; ANOVA analysis followed by Bonferroni's post-hoc analysis was performed, *P <0.01 for differences between groups; n = 10).
Fig. 2.
A. Representative wave forms of both scotopic and photopic ERG responses. B. Photopic and scotopic b-waves in the MNU group were almost undetectable. However, the ERG function in the MNU+αBC group was less impaired: the amplitudes of photopic and scotopic b-wave in the MNU+αBC group were significantly larger compared with the MNU group (All the values were presented as mean ±SD; ANOVA analysis followed by Bonferroni's post-hoc analysis was performed, *P <0.01, for differences between groups; n = 10).
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0.01; n = 10). Although visual acuity and contrast sensitivity of the MNU+αBC group were lower compared with the normal controls (visual acuity: P < 0.01, n = 10, Fig. 1 .C; contrast sensitivity: P < 0.05, n = 10, Fig. 1.D) , these results suggeste that αBC therapy could improve the optokinetic function of MNU administered mice. Subsequently, the experimental animals were subjected to ERG examination and the representative ERG wave forms of each group are shown in Fig. 2 .A. As expected, both the photopic and scotopic b-waves of the MNU group were almost undetectable. However, the MNU+αBC group exhibited less impaired ERG function: both photopic and scotopic b-wave amplitudes of the MNU+αBC group were significantly larger compared with the MNU group (P < 0.01; n = 10, Fig. 2.B) . It is noteworthy that photopic and scotopic b-wave amplitudes in the MNU+αBC group were respectively approximately 52% and 67% of those in the normal control group, indicating that cone function was preferentially rescued by αBC.
αBC induced protective effects on retinal morphometry
In order to determine the αBC induced effects on retinal appearance, we photographed the mice using a fundus camera. Fundus photographs of the MNU group showed prominent damage due to MNU administration, as typified by the abundance of yellow-whitish lesions that spread throughout all retinal sectors (Fig. 3.A) .In contrast, there were fewer lesions in the MNU+αBC group than in the MNU group. In particular, the lesions were devoid of pigments and were much smaller than the lesions in the MNU group. Subsequently, retinal thickness was assessed by SD-OCT examination in vivo (Fig. 3.B) . The retinal organization of the MNU group was markedly disrupted by MNU administration. Retinal thickness was substantially reduced compared with the normal controls (P < 0.01; n = 10, Fig. 3.C) . Retinal thickness in the MNU+αBC group was also significantly reduced compared with the normal control group (P < 0.01; n = 10). Nevertheless, retinal thickness in the MNU+αBC group was significantly increased compared with the MNU group, indicating that MNU induced morphological impairment could be partially alleviated by αBC treatment.
αBC induced protective effects on photoreceptors
The ONL thickness of HE stained sections was quantified to determine the αBC induced protective effects on photoreceptors. The ONL in the retinas of the MNU group disappeared after MNU administration. Conversely, a large proportion of the ONL was Fig. 3 . A. Fundus photographs showed that the retinal appearance in the MNU group was devastated markedly, as typified by the abundance of yellow-whitish lesions that spread throughout all retinal sectors. Conversely, there were fewer lesions in the MNU+αBC group compared with the MNU group. B. Mice were subjected to SD-OCT examination and their retinal thicknesses were quantified. C. Retinal thickness in the MNU group was significantly smaller than that in the normal controls. Retinal thickness in the MNU+αBC group was significantly larger compared with the MNU group. D. ONL in the retinal sections of the MNU group disappeared. A large proportion of ONL was preserved in the retina sections of MNU+αBC group. E. The mean ONL thickness in the MNU+αBC group was significantly larger compared with the MNU group. (All the values were presented as mean ±SD; ANOVA analysis followed by Bonferroni's post-hoc analysis was performed, *P <0.01, for differences between groups; n = 10; GCL: Ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: nuclear layer). retained in the retinas of the αBC group (Fig. 3.D) . The mean ONL thickness in the αBC group was significantly increased compared with the MNU group (P < 0.01; n = 10, Fig.  3.E) . Furthermore, the TUNEL assay was performed to quantify the apoptotic activity in photoreceptors. A previous study had shown that the MNU induced apoptotic activation peaked at 3 days post administration(P3), and then returned to the baseline around P7 [22] . Therefore, we performed the TUNEL assay at P3 to capture the most evident changes (Fig. 4) . No TUNEL -positive cell was detected in the retinas of the normal control group. In contrast, many TUNEL -positive cells were found in the retinas of the MNU group. In particular, most of the TUNEL-positive cells were concentrated in the ONL, suggesting that MNU toxicity induced massive photoreceptor apoptosis in mice retinas. TUNEL-positive cells were also detected in the retinas of the MNU+αBC group. However, the AI in the MNU+αBC group was significantly smaller than that in the MNU group (P<0.01; n=10), suggesting that αBC treatment could alleviate the MNU induced photoreceptor apoptosis. As rods account for the major photoreceptor population in murine retinas(~97%), the ONL should be considered as an indicator of rod vitality. Whether the minor population of cones(~3%) were effectively rescued by αBC treatment could not be deduced from HE stained sections. Consequently, we performed immunostaining to determine the vitality of cones (Fig. 5.A) . Typical PNA staining was detected in both the normal control and MNU+αBC groups, but rarely in the MNU group. Specifically, we analyzed the immune fluorescence with M-and S-opsin antibodies. M-opsin staining was detected throughout the retina of the MNU+αBC group, although with a decreased intensity compared with the normal control group. Conversely, no S-opsin staining was detected in any part of the retinas in the MNU+αBC group, indicating different sensitivities to αBC treatment in the cone populations.
Furthermore, another group of mice (n=10) was randomly selected and received an TUNEL-positive cells were also found in the retinas of the MNU+αBC group. The AI of the MNU+αBC group was significantly smaller compared with the MNU group(P<0.01; n=10), suggesting that αBC treatment could alleviate MNU induced photoreceptor apoptosis (All the values were presented as mean ±SD; ANOVA analysis followed by Bonferroni's post-hoc analysis was performed, *P <0.01, for differences between groups; n = 10).
Fig. 5.
A. Immunostaining works on the retinal sections of mice from different groups. PNA staining was detected in the retinas of both normal control group and MNU+αBC group, but rarely in the MNU group. M-opsin staining was detected throughout the retina of the MNU+αBC group, although with a decreased intensity compared with the normal control group. Of note, no S-opsin staining was found in the retinas of the MNU+αBC group. B. Protein levels of STAT3, phosphorylated STAT3 and JAK in the MNU+αBC group were significantly higher compared with the MNU group, suggesting that JAK/ STAT3 signal pathway was activated by αBC treatment. (All the values were presented as mean ±SD; ANOVA analysis followed by Bonferroni's post-hoc analysis was performed, *P <0.01, for differences between groups; n = 10).
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry intravitreal injection of heparin (2 μl, 50U/ml) 2 h post MNU administration. One week later, these heparin treated mice were subjected to functional evaluation. The mean amplitudes of ERG b-waves in heparin treated mice were not significantly different from those in the MNU group (P > 0.05, n = 10). In the optokinetic tests, both visual acuity and contrast sensitivity in the heparin treated group were not significantly different from those in the MNU group (P > 0.05, n = 10). Moreover, mean ONL thickness in the heparin treated mice was not significantly different from that in the MNU group (P > 0.05, n = 10). Taken together, these findings suggest that intravitreal injection of heparin, a protein unrelated to small heat shock protein, would not affect retinal function or morphology [26] . Alternatively, the aforementioned beneficial effects could be unique to αBC rather than simply caused by the surgical procedures of intravitreal injection.
Mechanisms underlying the αBC induced protection
We performed the qRT-PCR to analyse the underlying mechanisms related to the αBC induced effects. The retinal mRNA levels of both Bax and Caspase-3 in the MNU+αBC group were significantly lower than those in the MNU group (P < 0.01; n = 10, Fig. 6 ). Meanwhile, the mRNA levels of Bcl-2 and CNTF in the MNU+αBC group were significantly higher than Fig. 7 . Protein levels of Bax and Caspase-3 in the MNU+αBC group were significantly lower compared with the MNU group. Moreover, protein levels of Bcl-2 and CNTF in the MNU+αBC group were significantly higher compared with the MNU group. Additionally, the protein level of BDNF in the MNU+αBC group was not significantly different from that in the MNU group. (All the values were presented as mean ±SD; ANOVA analysis followed by Bonferroni's post-hoc analysis was performed, *P <0.01, # P <0.05 for differences between groups; n = 10). Fig. 8 . A. MDA concentration in the MNU+αBC group was significantly lower compared with the MNU group. SOD level in the MNU+αBC group was significantly higher compared with the MNU group, suggesting that oxygen stress was effectively alleviated by αBC treatment. Mn-SOD level in the MNU group was significantly lower compared with the normal control group, whereas Mn-SOD level in the MNU+αBC group was significantly higher compared with the MNU group ( All the values were presented as mean ±SD; ANOVA analysis followed by Bonferroni's post-hoc analysis was performed, *P <0.01, for differences between groups; n = 10). Fig. 6 . The mRNA levels of Bax and Caspase-3 in the MNU+αBC group were significantly lower compared with the MNU group (P<0.01; n = 10), whereas the mRNA levels of Bcl-2 and CNTF in the MNU+αBC group were significantly compared with the MNU group (P<0.01; n = 10). The mRNA level of BDNF in the MNU+αBC group was not statistically different from that in the MNU group (P>0.05; n = 10; All the values were presented as mean ±SD; ANOVA analysis followed by Bonferroni's post-hoc analysis was performed, *P <0.01, for differences between groups; n = 10).
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those in the MNU group (P < 0.01; n = 10), indicating that neurotrophic and anti-apoptotic mechanisms contributed collectively to the αBC induced protective effects. Of note, the mRNA level of BDNF in the MNU+αBC group was not significantly different from the level in the MNU group (P>0.05; n = 10). The protein levels of Bax and Caspase-3 in the MNU+αBC group were significantly lower than those in the MNU group (P < 0.01; n = 10; Fig.7) , whereas the protein levels of Bcl-2 and CNTF in the MNU+αBC group were significantly higher than that in the MNU group (P < 0.01; n = 10). Additionally, the protein level of BDNF in the MNU+αBC group was not significantly different from that in the MNU group (P>0.05; n = 10). These western blotting data were consisted with the qRT-PCR results. Furthermore, the protein levels of STAT3, phosphorylated STAT3 and JAK in the MNU+αBC group were significantly higher than those in the MNU group (P < 0.01, n = 10, Fig. 5.B) . These findings suggested that JAK/STAT3 signal pathway was activated after αBC treatment. Furthermore, the MDA concentration in the MNU+αBC group was significantly lower than that in the MNU group (P < 0.01; n = 10, Fig. 8.A) . Conversely, the SOD level in the MNU+αBC group was significantly higher (P < 0.01; n = 10, Fig. 8.B) , suggesting that oxygen stress was effectively alleviated by αBC treatment.
The Mn-SOD level in the MNU group was significantly lower than the normal controls (P < 0.01; n = 10; Fig. 8 .C), whereas the Mn-SOD level in the MNU+αBC group was significantly higher than that in the MNU group (P < 0.01; n = 10), suggesting that αBC conferred critical protection against mitochondrial insults during MNU induced photoreceptor apoptosis.
Discussion
Crystalline, a member of the small heat shock protein family, is a major constitute of the lens. In addition to acting as a static structural protein within the ocular compartments, crystalline confers anti-apoptotic and nutritional effects [27] . There is general agreement that crystallin is necessary to maintain retinal homeostasis. Following traumatic or toxic assault of the retina, endogenous αBC is released from the ocular lens, thereby maintaining high intravitreal concentrations [14] . Notably, endogenous αBC is also secreted by human RPE cells in the form of exosomes, which are released into the extracellular matrix and absorbed by adjacent retinal cells [28] . Theses adaptive activities provide a primary defense against undesirable outcomes of cellular stress, highlighting the possibility that αBC might be used therapeutically [29, 30] . To date, the αBC induced protection has been demonstrated in various cell cultures including RPE cells, astrocytes, endothelial cells, and pericytes [31] . A pioneering therapeutic study showed that intravitreal delivered β-crystallins or γ-crystallins exerted nutritional effects on the RGCs after optic nerve crush. However, deposition of the exogenous α-crystalline within the vitreous cavity failed to produce similar cytoprotective effects [24] . Therefore, we injected the αBC into the vitreous cavity of MNU administered mice to verify its feasibility for RP therapy.
Here, we showed that intravitreal delivered αBC could ameliorate MNU induced photoreceptor degeneration. Since traditional systemic administration has limitations such as rapid protein clearance and unexpected off-target effects, targeted intravitreal delivery can warrant higher concentrations of αBC in the intended tissue. The optokinetic behavioral test and ERG examination suggested that visual function of the MNU+αBC group is efficiently rescued. Subsequent OCT analysis showed that the main retinal architecture of the MNU+αBC group was preserved by αBC treatment. The size of lesion was markedly reduced by αBC treatment as shown in the fundus photographs. In particular, the immunostaining study suggested that photoreceptor populations had different sensitivities to αBC. Taken together, our findings highlight a unique therapeutic potential for αBC. In previous studies, αBC has been used to treat several ophthalmological diseases, such as optic nerve crush, autoimmune uveoretinitis, diabetic retinopathy, corneal neovascularization, and selenite induced cataracts [11] . In the retina, αBC can counteract the sodium iodate induced photoreceptor degeneration [32] . All these findings highlight the opportunity to develop a promising therapeutic tool for retinopathy. αBC is a potent anti-apoptotic protein that interacts with apoptotic mediators. Moreover, prominent αBC expressions in the mitochondria could prevent activation of the apoptotic cascade [18, 32] . On the other hand, apoptosis is a pivotal contributory factor to RP. In accordance with this notion, the major attribute of the αBC induced protection appears to be anti-apoptosis. In MNU administered mice, the retinal expressions of Bax and Caspase-3, two critical mediators of apoptosis, were down-regulated after αBC treatment. On the other hand, the retinal expression of bcl-2, an anti-apoptotic factor was up-regulated after αBC treatment. These findings suggest that adjustment of the apoptotic threshold can serve as a protective strategy against RP. αBC can also translocate to the mitochondrial voltagedependent anion channels, thereby alleviating oxidative stress [14] . Additionally, αBC can protect the retinal cells against excessive ER stress, which is associated with bursts of reactive oxygen species(ROS) and superoxide dismutase depletion [17] . This notion is reinforced by the fact that silencing of αBC exacerbates oxidative stress. whereas the over-expression has the opposite effect [33] . In the present study, we have shown that αBC treatment enhances retinal SOD activity and reduces MDA concentration in MNU administered mice. Furthermore, the CNTF expression was up-regulated and its major downstream signaling pathway (JAK/ STAT3) was activated after αBC treatment. These alterations would provide essential nutritional support for photoreceptors. Independently, another study also suggested that exogenous β crystalline enhanced the CNTF expression in retinal astrocytes. JAK/STAT3 activation was involved in this beneficial effects and was proposed as a necessary prerequisite for axon regeneration in RGCs [24] . Collectively, these findings raise the possibility that αBC supplementation might afford protection against photoreceptor degeneration. αBC is also reported to be anti-inflammatory owing to its chaperone activity to bind with inflammatory molecules such as Toll-like receptors, interferon-γ, nuclear factor-kβ, tumor necrosis factor-α, interleukin-6 [34] . Intravenous administration of αBC alleviates the inflammatory response in endophthalmitis and uveitis models [31, 35] . On the other hand, chronic inflammation is recognized as an etiological factor in RP pathogenesis. Inflammatory cells and proteins in the vitreous body increase significantly in RP patients [36] . Preclinical trials targeting activated microglia in the outer retina have already demonstrated impressive benefits in RP animal models [37] . In this context, it is highly plausible that the anti-apoptotic activity of αBC might act together with its anti-inflammatory activity to cause favorable effects. Further investigations are needed to unravel the detailed role of αBC during the neuroprotection.
Mitochondria are considered as the central regulators of apoptotic cell death that mediate stress signals between critical organelles. Impaired mitochondrial function is closely associated with apoptosis of retinal neuron [17, 29] . In this study, the αBC could enhance the Mn-SOD activity in the MNU+αBC group, suggesting that αBC confers critical mitochondrial protection during photoreceptor apoptosis. Moreover, the mitochondrial ROS assay is another method to evaluate the severity of oxidative stress. This examination reliably reflects the αBC induced effects on mitochondrial function. It is highly possible that αBC would also affect the mitochondrial ROS activity in MNU administered mice. Further studies are necessary to quantify the αBC induced effects on mitochondrial ROS.
More than 100 gene mutations that initiate RP have been characterized. These mutations are restricted exclusively to the rod photoreceptors which are responsible for night vision. However, apoptosis of the rods is followed by secondary cone loss [3] . Since cones are not directly affected by primary mutations, the causes of cone loss as well as protection represent the main challenges in RP research [38] . As long as the cones are rescued, RP patients would be able to function well under bright conditions and lead relatively normal lives despite the primary loss of rods [39, 40] . To our knowledge, this is the first study to report the αBC induced protection on cones. Accordingly, it would be of great value to develop a cone rescuing reagent to maintain daily vision of RP patients. Specifically, the Mcone photoreceptors, rather than the S-cone photoreceptors, in MNU administered mice are efficiently rescued byαBC treatment. In mouse retina, the cone photoreceptors are not evenly distributed, and each subtype forms a gradient across the retinal regions: S-cone photoreceptors are mainly distributed in the inferior hemisphere, particular the nasal- inferior quadrant; M-cone photoreceptors are mainly distributed in superior hemisphere [21, 41] . On the other hand, the focal photoreceptors show different vulnerabilities to MNU toxicity and displayed positional asymmetry among the retinal quadrants [42] [43] [44] . These photoreceptors in the nasal-inferior quadrant are most vulnerable to MNU toxicity and the impairment in this region is most severe. Conversely, the photoreceptors in the temporalinferior quadrant are most resistant to MNU toxicity and the impairment in this region is least severe. Therefore, the relative number and distribution of photoreceptor populations across retinal regions closely correlate with the differences in "protective effects". It may be more difficult to rescue with therapeutic agents the S-cones which are concentrated in the nasal-inferior quadrant. Future studies are necessary to verify this proposal.
In conclusion, intravitreal delivery of αBC can alleviate photoreceptor degeneration in MNU administered mice. αBC induced protection might stem from anti-apoptotic, anti oxidative and nutritional attributes. Our findings highlight the possibility that intravitreal delivery of αBC might be a promising strategy for the treatment of RP. Further studies on the dosage regimens, delivery route, and intervention time points would be of great importance for αBC therapy.
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